| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5690343 | Urology | 2017 | 25 Pages |
Abstract
Neoadjuvant axitinib resulted in a decrease in skeletal muscle and subcutaneous adipose tissue, as well as weight loss. Patients with baseline sarcopenia tended to have a lower response rate to neoadjuvant axitinib.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Lisly Chéry, Leonardo D. Borregales, Bryan Fellman, Diana L. Urbauer, Naveen Garg, Nathan Parker, Matthew H.G. Katz, Christopher G. Wood, Jose A. Karam,